Common use of Adverse Drug Experience Reporting Clause in Contracts

Adverse Drug Experience Reporting. Each Party shall fully, accurately and promptly provide to the other Party with all data known to it at any time during the term of this Agreement or thereafter, which data indicate that any Product marketed by WCH is or may be unsafe, lacks utility, or otherwise does not meet Specifications in accordance with the Adverse Event Reporting Procedures set forth in Exhibit D attached hereto (as the same may be amended from time to time by notice in writing from WCH to IMPAX). WCH shall determine whether such information is required to be reported and report the same as required, to FDA and any other Regulatory Authority.

Appears in 4 contracts

Samples: Development, License and Supply Agreement (Impax Laboratories Inc), Development, License and Supply Agreement (Impax Laboratories Inc), Development, License and Supply Agreement (Impax Laboratories Inc)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.